Obesity and cancer;Obésité et cancer

Revue de Medecine Interne

Volumn 30, Issue 9, 2009, Pages 776-782

  Schlienger, J L ^a   Luca, F ^a   Vinzio, S ^a   Pradignac, A ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Cancer; Hyperinsulinism; IGF 1; Obesity

Indexed keywords

ADIPONECTIN; AROMATASE; ESTRADIOL; INSULIN; LEPTIN; SEX HORMONE BINDING PROTEIN; SOMATOMEDIN C;

APOPTOSIS; BODY MASS; BREAST CANCER; CALORIC INTAKE; CANCER RISK; CANCER SURVIVOR; COLON CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ESOPHAGEAL ADENOCARCINOMA; ESTRADIOL BLOOD LEVEL; HUMAN; HYPERINSULINISM; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MITOGENICITY; NONHUMAN; OBESITY; PATIENT SAFETY; PHYSICAL ACTIVITY; PROGNOSIS; RISK REDUCTION; SHORT SURVEY; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; ESOPHAGEAL NEOPLASMS; EXERCISE; FEMALE; HUMANS; HYPERINSULINISM; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; NEOPLASMS; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK; RISK FACTORS; SEX FACTORS;

EID: 69949085011     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.04.007     Document Type: Short Survey

References (53)

1. Expert panel on the identification, evaluation and treatment of overweight and obesity in adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6:51S-209S.
2. IARC working group on the evaluation of cancer-preventive agents. Weight control and physical activity, IARC handbooks of cancer prevention, volume 6. IARC 2002.
3. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348 (2003) 1625-1638
4. Renehan A.G., Tyson M., Heller F.R., and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008) 569-578
5. Larsson S.C., and Wolk A. Obesity and risk of non-hodgkin's lymphoma: a meta-analysis. Int J Cancer 121 (2007) 1564-1570
6. International agency for research on cancer (WHO): IARC handbooks of cancer prevention. Weight control and physical activity. IARC 2002.
7. Willett W.C. Diet and Cancer. Oncologist 5 (2000) 393-404
8. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D., et al. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ 335 (2007) 1134-1144
9. Huang Z., Willett W.C., Colditz G.A., Hunter D.J., Manson J.E., Rosner B., et al. Waist circumference waist-hip ratio and risk of breast cancer in the nurses' health study. Am J Epidemiol 150 (1999) 1316-1324
10. Huang Z., Hankinson S.E., Colditz G.A., Stampfer M.J., Hunter D.J., and Manson J.E. Dual effects of weigth and weight gain on breast cancer risk. J Am Med Assoc 278 (1997) 1407-1411
11. Trentham-Dieth A., Newcomb P.A., Egan K., Titus-Ernstoff L., Baron J.A., et al. Weight change and risk of postmenopausal breast cancer. Cancer Causes Control 11 (2000) 533-542
12. Blackburn G.L., and Wang K.A. Dietary fat reduction and breast cancer outcome: results from the women's intervention nutrition study (WINS). Am J Clin Nutr 86 (2007) 878S-881S
13. Wu A.H., Pike M.C., and Stram D.O. Meta-analysis: dietary fat intake, serum estrogen levels and risk of breast cancer. J Natl Cancer Inst 91 (1999) 529-534
14. Trentham-Dietz A., Nichols H.B., Hampton J.M., and Newcomb P.A. Weight change risk of endometrial cancer. Int J Epidemiol 35 (2006) 151-158
15. Beehler G.P., Sekhon M., Baker J.A., Teter B.E., Mc Cann S.E., Rodabaugh K.J., et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136 (2006) 2881-2886
16. Mac Innis R.J., and English D.R. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17 (2006) 989-1003
17. Hsing A.W., Sakoda L.C., and Chua Jr. C. Obesity, metabolic syndrome and prostate cancer. Am J Clin Nutr 86 (2007) 843S-857S
18. Larsson S.C., Rutegard J., Bergkvist L., and Wolk A. Physical activity, obesity and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer 42 (2006) 2590-2597
19. Giovannucci E. Metabolic syndrome, hyperinsulinemia and colon cancer: a review. Am J Clin Nutr 86 (2007) 836S-842S
20. Gunter M.J., and Leitzmann M.F. Obesity and colorectal cancer. Epidemiology, mechanisms and candidate genes. J Nutr Biochem 17 (2006) 145-156
21. Chow W.H., Blot W.J., Vaughan T.L., Risch H.A., Gammon M.D., and Stanford J.L. Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia. J Natl Cancer Inst 90 (1998) 150-155
22. Lagergren J., Ye W., Berstrom R., and Nyren O. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA 284 (2000) 961-962
23. Patel A.V., Rodriguez C., Bernstein L., Solomon L., Thun M.J., and Calle E.E. Obesity, recreational physical activity and risk of pancreatic cancer in a large US cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 459-466
24. Larsson S.C., and Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97 (2007) 1005-1008
25. Lindblad P., Wolk A., Bergström R., Persson I., and Adami H.O. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 3 (1994) 631-639
26. Chow W.H., Gridley G., Fraumeni J.F., and Järvholm B. Obesity, hypertension and the risk of kidney cancer in men. N Engl J Med 343 (2000) 1305-1311
27. Adams K.F., Leitzmann M.F., Albanes D., Kipnis V., Moore S.C., Schatzkin A., et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168 (2008) 268-277
28. Larsson Sc, and Wolk A. Obesity and risk of gall bladder cancer: a meta-analysis. Br J Cancer 96 (2007) 1457-1461
29. Larsson S.C., and Wolk A. Overweight and obesity and incidence of leukaemia: a meta-analysis of cohort studies. Int J Cancer 122 (2008) 1418-1421
30. Pisani P. Hyper-insulinamia and cancer, meta-analysis of epidemiological studies. Arch Physiol Biochem 114 (2008) 63-70
31. Goodwin P.J., Ennis M., Pritchard K.L., Trudeau M.E., Koo J., Hartwick W., et al. Fasting insulin and outcome in early-stage breast cancer. Results of a prospective cohort study. J Clin Oncol 20 (2002) 42-51
32. Papa V., and Belfiore A. Insulin receptors in breast cancer. Biological and clinical role. J Endocrinol Invest 19 (1996) 324-333
33. Evans J.M., Donnelly L.A., Emslie-Smith A.M., Alessi D.R., and Morris A.D. Metformin and reduced risk cancer in diabetic patients. BMJ 330 (2005) 1304-1305
34. Dossus L., and Kaaks R. Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 22 (2008) 551-571
35. Rose D.P., Gilhooly E.M., and Nixon D.W. Adverse effects of obesity on breast cancer prognosis and the biological actions of leptin. Int J Oncol 21 (2002) 1285-1292
36. Mioshi Y., Funahashi T., Tanaka S., Taguchi T., Tamaki Y., Shimomura I., et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118 (2006) 1414-1419
37. Cong L., Gasser J., Zhao J., Yang B., and Zhao A.Z. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-1 and RL95 2. Endocr Relat Cancer 14 (2007) 713-720
38. Dieudonne M.N., Bussiere M., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345 (2006) 271-279
39. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insuline-like growth factor (IGF-1), IGF binding protein-3 and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
40. Gunter M.J., Hoover D.R., Yu H., Wassertheil-Smoller S., Rohan T.E., Manson J.E., et al. Insulin, insulin-like growth factor I endogenous estradiol and risk of colorectal cancer in postmenopausal women. Cancer Res 68 (2008) 329-337
41. Allen N.E., Roddam A.W., Allen D.S., Fentiman F.S., Dos Santos Silva I., Peto J., et al. A prospective study of serum insulin-like growth factor-I (IGF-1), IGF-II, IGF-binding protein-3 and beast cancer risk. Br J Cancer 92 (2005) 1283-1287
42. Lukanova A., Lundin E., Zeleniuch-Jacquotte A., Muti P., Mure A., Rinaldi S., et al. Body mass index, circulating levels of sex-steroid hormones. IGF-1 and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150 (2004) 161-171
43. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth-factor 1. Proc Nutr Soc 60 (2001) 91-106
44. Stoll B.A. Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. Ann Oncol 13 (2002) 191-196
45. Roddam A.W., Allen N.E., and Appleby P. Endogenous sex hormone and prostate cancer: collaborative analysis of 18 prospective studies. J Natl Canc Inst 100 (2008) 170-183
46. Purohit A., Newman S.P., and Reed M.J. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4 (2002) 65-69
47. Heikkilä K., Ebrahim S., and Lawlor D.A. A systematic review of the association between circulating concentrations of C-reactive protein and cancer. J Epidemiol Community Health 61 (2007) 824-833
48. Baillargeon J., and Rose D.P. Obesity adipokines and prostate cancer. Int J Oncol 28 (2006) 737-745
49. Wei H. Activation of oncogenes and/or inactivation of anti-oncogenes by reactive oxygen species. Med Hypotheses 39 (1992) 267-270
50. Lee I.M. Physical activity and cancer prevention - data from epidemiologic studies. Med Sci Sports Exerc 35 (2003) 1823-1827
51. Samad A.K.A., Taylor R.S., Marshall T., and Chapman M.A.S. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 7 (2005) 204-213
52. Holmes M.D., Chen W.Y., Feskanich D., Kroenke C., and Colditz G.A. Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005) 2479-2486
53. Adamsen L., Midtgaard J., Rorth M., Borregaard N., Andersen C., Quist M., et al. Feasibility, physical capacity and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care Cancer 11 (2003) 707-716